Advertisement
Collaboration › Details
Prilenia–Leucadia: investor conference, 202006 supply service Prilenia presents at Jefferies 2020 Virtual Healthcare Conference
Period | 2020-06-03 | |
Partner, 1st | Prilenia Therapeutics B.V. | |
Group | Prilenia (Group) | |
Partner, 2nd | Jefferies LLC | |
Group | Leucadia (Group) | |
Product | Jefferies 2020 Virtual Healthcare Conference DIGITAL | |
Product 2 | pridopidine | |
Person | Hayden, Michael R. (Forbion 202203– Venture Partner + Prilenia Therapeutics 202006– CEO former CSO at Teva) | |
Source | Prilenia Therapeutics B.V.. (6/3/20). "Press Release: Presentation by Dr. Michael Hayden at the Jefferies Virtual Conference". | |
Record changed: 2020-06-06 |
Advertisement
More documents for Prilenia (Group)
- [1] Forbion Capital Partners. (3/31/22). "Press Release: Forbion Appoints Both Dr Ton Logtenberg and Dr Michael Hayden as Venture Partners". Naarden....
- [2] Prilenia Therapeutics B.V.. (6/3/20). "Press Release: Prilenia Therapeutics Raises $62.5m to Fund Late Stage Trials in HD and ALS". Naarden & Herzliya....
- [3] Prilenia Therapeutics B.V.. (6/3/20). "Press Release: Presentation by Dr. Michael Hayden at the Jefferies Virtual Conference"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top